Potential strategies for inflammatory mediator manipulation: retrospect and prospect

Area of Science:

• Critical care medicine
• Infectious diseases
• Pharmacology

Background:

• Sepsis syndrome and septic shock are major causes of illness and death.
• Despite extensive animal research, novel sepsis treatments have not succeeded in clinical trials.
• There is a critical need to understand why these therapies fail.

Purpose of the Study:

• To review recent major clinical trials for sepsis treatment.
• To discuss the scientific hypotheses behind these therapeutic strategies.
• To identify critical issues hindering clinical success and recommend future trial designs.

Main Methods:

• Literature review of major sepsis clinical trials.
• Analysis of therapeutic hypotheses and their translation from animal models.
• Discussion of challenges in clinical sepsis research.

Main Results:

• Recent clinical trials of novel sepsis agents have not shown efficacy.
• Discrepancies exist between animal model efficacy and human clinical trial outcomes.
• Key challenges in sepsis trial design and patient selection persist.

Conclusions:

• Novel sepsis therapies require re-evaluation based on clinical trial outcomes.
• Future sepsis trials must address critical issues in design and methodology.
• Improved understanding of sepsis pathophysiology is crucial for therapeutic development.